R&D Productivity Ranking Methodology
Executive Summary
Catenion's methodology for evaluating R&D productivity of the world's 30 largest public pharmaceutical companies, as judged by sales.
You may also be interested in...
Value-Based R&D Pharma Productivity 2015: Oncology And Hep C Drive Top Performers
Catenion updates its annual list of the year's top pharma R&D performers, based on R&D productivity and growth.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.